Carcinoma, Adenosquamous
Showing 1 - 25 of 7,815
Adenosquamous Carcinoma of the Pancreas Trial run by the NCI (Minnelide)
Recruiting
- Adenosquamous Carcinoma of the Pancreas
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 7, 2022
Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,
Not yet recruiting
- Pancreatic Acinar Cell Carcinoma
- +6 more
- Nab paclitaxel
- +5 more
- (no location specified)
Oct 30, 2023
Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,
Recruiting
- Pancreatic Cancer
- +3 more
- ZIMBERELIMAB
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 9, 2023
Sputum DNA Testing for Lung Cancer in China
Recruiting
- Lung Cancer
- +15 more
- Diagnostic Test: Sputum DNA methylation analysis
- chest CT or pathological examination
-
Guangzhou, Guangdong, ChinaNanfang Hospital of Southern Medccal University
Dec 29, 2022
Stage IV Cervical Cancer FIGO 2018, Adenosquamous Carcinoma of Cervix, Cervical Cancer Trial in Dallas (Ultra-fractionated
Recruiting
- Stage IV Cervical Cancer FIGO 2018
- +3 more
- Ultra-fractionated radiation therapy
-
Dallas, TexasUT Southwestern Medical Center
Apr 29, 2022
HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T
Not yet recruiting
- HPV-Associated Cervical Carcinoma
- +16 more
- Conditioning, E7 TCR-T cells, and aldesleukin
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 17, 2023
Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)
Not yet recruiting
- Cervical Cancer
- +20 more
- E7 TCR-T cells
-
New Brunswick, New Jersey
- +1 more
Jan 18, 2023
Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,
Not yet recruiting
- Head and Neck Cancer
- +20 more
- TSC-204-A0201
- +4 more
-
Scottsdale, Arizona
- +1 more
Aug 3, 2023
Cervical Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma Trial in France, Italy, Spain (Standard treatment: Control arm,
Not yet recruiting
- Cervical Carcinoma
- +2 more
- Standard treatment: Control arm
- Experimental arm
-
Bordeaux, France
- +18 more
Oct 12, 2022
Hybrid PET/MR in the Therapy of Cervical Cancer
Completed
- Cervix Carcinoma
- +2 more
- FDG PET/MR
-
Chapel Hill, North CarolinaUniversity of North Carolina-Chapel Hill
Dec 2, 2021
Human Papilloma Virus Circulating Tumor DNA in Cervical Cancer
Recruiting
- Cervical Adenosquamous Carcinoma
- +26 more
- Biospecimen Collection
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
ESCC or Esophageal Adenosquamous Carcinoma Trial in Guangzhou (HLX07+HLX10+ Cisplatin+5-FU, HLX07)
Recruiting
- ESCC or Esophageal Adenosquamous Carcinoma
- HLX07+HLX10+ Cisplatin+5-FU
- HLX07
-
Beijing, Beijing, China
- +16 more
Aug 25, 2022
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Recruiting
- Cervical Adenocarcinoma
- +11 more
- Media Intervention
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jun 15, 2022
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States
Completed
- Endometrial Adenocarcinoma
- +4 more
- Akt Inhibitor MK2206
- Laboratory Biomarker Analysis
-
Boston, Massachusetts
- +6 more
Jan 13, 2022
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Withdrawn
- Cervical Adenocarcinoma
- +6 more
- Carboplatin
- +4 more
-
Cape Town, South Africa
- +2 more
Jun 14, 2022
MRI and PET Imaging in Predicting Treatment Response in Stage
Active, not recruiting
- Cervical Adenocarcinoma
- +12 more
- Computed Tomography
- +5 more
-
Miami, Florida
- +5 more
Oct 4, 2022
Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,
Recruiting
- Cervical Adenocarcinoma
- +47 more
- Bevacizumab
- +3 more
-
Phoenix, Arizona
- +3 more
Dec 5, 2022
Uterine Cervical Tumors, Squamous Cell Carcinoma, Adenocarcinoma Trial in Canada (Metformin, Cisplatin, FAZA)
Completed
- Uterine Cervical Neoplasms
- +3 more
- Metformin
- +2 more
-
Calgary, Alberta, Canada
- +4 more
Apr 19, 2021
Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma Trial in
Active, not recruiting
- Endometrial Adenosquamous Carcinoma
- +9 more
- Cabozantinib S-malate
- +2 more
-
Duarte, California
- +18 more
Oct 15, 2022
Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma, Advanced Cervical Squamous Cell Carcinoma Trial in
Recruiting
- Advanced Cervical Adenocarcinoma
- +12 more
- Biospecimen Collection
- +11 more
-
Los Angeles, California
- +15 more
Aug 23, 2022
Cervical Squamous Cell Carcinoma, Adenosquamous Carcinoma, Adenocarcinoma Trial in Houston, Brussels (Extraperitoneal
Completed
- Cervical Squamous Cell Carcinoma
- +4 more
- Extraperitoneal laparoscopic lymphadenectomy (EPLND)
- Chemoradiation
-
Houston, Texas
- +2 more
Jan 13, 2021
Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,
Recruiting
- Gynecologic Cancer
- +11 more
- Neoantigen specific TCR-T cell drug product
- Aldesleukin (IL-2)
-
Houston, TexasMD Anderson Cancer Center
Jul 27, 2022
Lung Tumors, Squamous Cell Lung Cancer, Adenocarcinoma of the Lung Trial in Guangzhou (Icotinib)
Recruiting
- Lung Neoplasms
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jul 29, 2021
Pulmonary Adenosquamous Carcinoma Trial in China (Almonertinib, Paclitaxel and carboplatin)
Not yet recruiting
- Pulmonary Adenosquamous Carcinoma
- Almonertinib
- Paclitaxel and carboplatin
-
Beijing, China
- +14 more
Apr 17, 2020